FLATT BEN ANDERSON SR 4
4 · NATIONAL HEALTHCARE CORP · Filed Apr 13, 2026
Research Summary
AI-generated summary of this filing
NHC CIO Ben Flatt Sr. Exercises Options; Sells Shares for Taxes
What Happened
Ben Flatt (Senior VP & CIO of National Healthcare Corp, ticker NHC) exercised 3,734 stock options on 2026-04-09 at an exercise price of $53.94, resulting in $201,412 in exercise cost. To cover the exercise price and withholding taxes, 1,909 of the newly issued shares were withheld/disposed at a market value of $176.81 each (total ~ $337,530). The option award corresponding to the exercised options was reported converted (derivative reported disposed @ $0.00). Net shares retained from this transaction: 3,734 − 1,909 = 1,825 shares.
Key Details
- Transaction date: April 9, 2026 (Form 4 filed April 13, 2026 — timely).
- Option exercise: 3,734 shares acquired at $53.94 each; total exercise cost $201,412.
- Tax/Exercise withholding: 1,909 shares withheld/disposed at $176.81 each; total value ~$337,530.
- Net shares added to Flatt’s holdings from this event: 1,825 shares.
- Footnotes: F1 — options granted under the 2020 Omnibus Equity Incentive Plan on 3/8/2023 and exempt from Section 16(b) per Rule 16b-3(d); F2 — shares were withheld to pay the exercise price and tax withholding obligations; F3 — the form reports total beneficially owned shares after the transactions (amount not shown in this summary).
- Filing timeliness: Filed on Apr 13, 2026 for an Apr 9 transaction; this filing appears timely under the two-business-day SEC requirement.
Context
This was an option exercise with net settlement (a cashless-style result): options were converted into shares, and a portion of those shares were withheld to satisfy exercise price and tax withholding. Such withholding is a routine administrative step and does not necessarily indicate a change in the insider’s view of the company. The Rule 16b-3(d) exemption noted in the filing means the grant and exercise are treated as compliant with short-swing profit rules. For the exact post-transaction beneficial ownership number, consult the full Form 4 (footnote F3).
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-04-09$53.94/sh+3,734$201,412→ 23,284.055 total - Tax Payment
Common Stock
[F2][F3]2026-04-09$176.81/sh−1,909$337,530→ 21,375.055 total - Exercise/Conversion
Option to Purchase Common Stock
[F1]2026-04-09−3,734→ 0 totalExercise: $53.94From: 2024-03-08Exp: 2028-03-08→ Common Stock (3,734 underlying)
- 8,000
Option to Purchase Common Stock
Exercise: $94.10From: 2025-03-05Exp: 2029-03-05→ Common Stock (8,000 underlying) - 9,000
Option to Purchase Common Stock
Exercise: $90.62From: 2026-02-24Exp: 2030-02-24→ Common Stock (9,000 underlying) - 14,000
Option to Purchase Common Stock
Exercise: $157.13From: 2027-02-23Exp: 2031-02-23→ Common Stock (14,000 underlying)
Footnotes (3)
- [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
- [F2]Shares were withheld by the Company to pay the exercise price and withholding tax obligations.
- [F3]Total amount of shares beneficially owned following transactions reported on this form.